Healthy volunteers help test new drug M5542 for first time in humans
NCT ID NCT06577337
First seen Oct 31, 2025 · Last updated Apr 24, 2026 · Updated 18 times
Summary
This early-stage study tests a new drug called M5542 in 49 healthy adults. Participants receive a single injection and are monitored for side effects and how the drug moves through the body. The goal is to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Pharmacology Unit of Nuvisan GmbH
RECRUITINGNeu-Ulm, Germany
Conditions
Explore the condition pages connected to this study.